Pronator Syndrome

Pronator Syndrome is compression of the median nerve in the proximal forearm, most commonly between the two heads of pronator teres muscle.

The evidence base for this topic is dominated by a modern reframing that the main text only glances at: much of what is labelled "pronator syndrome" is actually compression at the lacertus fibrosus, diagnosable by three clinical signs.

• Lacertus (not pronator teres) as the primary site. A growing literature argues the lacertus fibrosus (bicipital aponeurosis) is frequently the true, and often sole, compression point — some authors call it "lacertus tunnel syndrome" and treat it as a distinct subset of pronator syndrome rather than a minor secondary site.
• Hagert's three clinical signs. The diagnosis is clinical: (1) weakness of median-innervated muscles distal to the lacertus (test FPL, the FDP to the index, and APB against resistance); (2) pain on pressure over the median nerve at the lacertus; and (3) a positive scratch-collapse test.
• The scratch-collapse test. The seated patient holds both arms adducted, elbows flexed 90 degrees, and resists the examiner's external-rotation force; the examiner lightly scratches the skin over the compression site (the lacertus), and a transient loss of external-rotation resistance (a brief "collapse") on the affected side is positive and localises the level.
• Why it matters. Because electrodiagnostics are usually normal, these clinical signs ARE the diagnosis — and recognising lacertus compression explains the roughly 10% of pooled surgical series who had already undergone a failed carpal tunnel release before the proximal lesion was found.

Key Investigations:

• NCS: Usually NORMAL (unlike CTS where prolonged latency expected)
• EMG: May show minimal changes in median muscles
• X-ray: Look for supracondylar process if ligament of Struthers suspected
• MRI: Assess for masses, anomalous muscles, nerve signal changes
• Diagnostic injection: Can confirm diagnosis if resolution of symptoms

The operative evidence for proximal median compression has shifted toward a minimally-invasive, awake approach that the classic open technique above does not describe.

• The WALANT paradigm. Release is increasingly performed wide-awake under local anaesthesia with lidocaine-adrenaline and no tourniquet (WALANT) through a small (about 2 cm) incision at the lacertus, as a day-case/ambulatory procedure with low morbidity.
• Intra-operative confirmation. Its defining advantage: because the patient is awake and un-tourniqueted, the return of median-muscle strength can be tested on the table immediately after release — an instant confirmation that the correct structure was decompressed (seen in essentially all patients in the awake series).
• The percutaneous option. An emerging ultrasound-guided percutaneous release of the lacertus (performed superficial to pronator teres under WALANT) reproduces the immediate strength return through a millimetric skin incision with same-week return to work.
• Outcomes and the caveat. Awake lacertus release gives large early functional gains (QuickDASH falling by roughly 25-45 points across series) with few complications; the caveats are careful case selection and the reminder that a persistent case may still need a carpal tunnel or superficialis-arcade release.

Incomplete decompression and persistent symptoms are common because: 1) Wrong initial diagnosis (was actually CTS or other condition), 2) Incomplete surgical release of all compression sites, 3) Coexisting CTS or cervical pathology.

Return to work: Light duty at 2-4 weeks. Full duty at 6-8 weeks for most occupations. Manual labor may require 8-12 weeks.

Surgical Outcomes:

• Overall success: 70-80% good to excellent results
• Complete relief: 50-60%
• Partial improvement: 20-30%
• No improvement: 10-20% (often wrong diagnosis)

Prognostic Factors:

Reasons for Failure:

• Wrong diagnosis (was CTS or radiculopathy)
• Incomplete surgical decompression
• Coexisting compression sites (double crush)
• Progression of symptoms post-operatively

Global epidemiology. Proximal median nerve entrapment is genuinely uncommon and historically under-recognised; it is roughly an order of magnitude less frequent than carpal tunnel syndrome. There is a female predominance (around 2:1 to 3:1 across recent series) and a working-age peak (late 30s to 50s). A recurring international observation is that a meaningful minority of patients — about 10% in pooled lacertus-release data — have already undergone a failed carpal tunnel release before the proximal lesion is recognised.

No dedicated registry. Unlike arthroplasty, peripheral nerve decompressions are not captured by national joint or implant registries (NJR, AJRR, AOANJRR, Swedish/Norwegian/NZJR). Evidence is therefore driven by case series, prospective cohorts and the 2025 PRISMA systematic review rather than registry data — a point worth stating explicitly in a viva.

Side-by-side guidance (no society has a stand-alone pronator-syndrome guideline):

High- vs limited-resource practice. Where ultrasound and WALANT theatres are available, image-guided or minimal-incision awake release is increasingly favoured, allowing intra-operative confirmation of returned strength and same-day discharge. In limited-resource settings the diagnosis remains primarily clinical (history, thenar sensory testing, resisted pronation and scratch-collapse test), open decompression under regional/general anaesthesia is standard, and a diagnostic local-anaesthetic block is a cheap, useful confirmatory step. Electrodiagnostics are helpful chiefly to exclude CTS and cervical radiculopathy rather than to confirm pronator syndrome, since they are frequently normal.

Documentation / consent points (exam-relevant, billing-agnostic): record palmar cutaneous sensory testing, an adequate conservative trial (3-6 months), the differential considered (CTS, AIN syndrome, C6/C7 radiculopathy, TOS), and consent covering persistent symptoms (20-30%), cutaneous nerve injury and incomplete relief.